Aurobindo plans to launch 19 drugs in US in next 3 quarters
Homegrown pharmaceuticals firm Aurobindo Pharma expects to launch 19 approved products that have an addressable market of USD 6.8 billion in the US in the next three quarters.
Sep 04, 2016, 11:38 AM IST